Torrent Pharmaceuticals Ltd Corporate Actions

Torrent Pharma announces acquisition of 3 anti-diabetes brands

 Copy Link

Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.

USFDA concludes Torrent Pharma’s inspection with VAI

 Copy Link

The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.

Torrent Pharma promoter to pare 2.9% stake via block deal

 Copy Link

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

Torrent Pharma Q2 Profit Soars 17.3%, Revenue Grows 8.6%

 Copy Link

When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.

Torrent Pharma’s Shelcal 500 fails CDSCO quality test

 Copy Link

In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.

Top 10 Stocks for today - 27th September, 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.

Torrent Pharma logs 20% y-o-y growth in Q1 net profit

 Copy Link

The company announced that its India business grew by 10% year on year in the June quarter, with sales rising to ₹1,635 Crore from ₹1,426 Crore in Q1 FY24.

Top 10 stocks for today – 24th July 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Bajaj Finance, Vedanta, etc.